The Modulation of Cell Plasticity by Budesonide: Beyond the Metabolic and Anti-Inflammatory Actions of Glucocorticoids
Open Access
- 11 April 2025
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (4) , 504
Abstract
The synthetic cortisol analog budesonide (BUD) is an essential drug employed to manage chronic inflammatory diseases in humans, mainly those involving gastroenteric and airway mucosa, such as rhinitis, laryngitis, bronchitis, esophagitis, gastritis, and colitis, with high levels of success. As a glucocorticoid, BUD prevents the expression of pro-inflammatory cytokines/chemokines and the recruitment of immune cells into the inflamed mucosa. However, emerging evidence indicates that BUD, unlike classical glucocorticoids, is also a potent modulator of stem and cancer cell behavior/plasticity. Certainly, BUD stabilizes cell–cell adhesions, preventing embryonic stem cell differentiation and inhibiting the development of 3D gastruloids. In addition, BUD inhibits the motile/invasive propensity of different cancer cells, including breast, lung, and pancreatic cancer. Finally, it prevents the infection of positive single-stranded human-infecting RNA viruses such as SARS-CoV-2. At a molecular level, BUD induces epigenetic changes and modifies the transcriptome of epithelial, stem, and cancer cells, providing molecular support to the immune cell-independent activity of BUD. Here, we performed an in-depth review of these unexpected activities of BUD, identified by unbiased drug screening programs, and we emphasize the molecular mechanisms modulated by this efficacious drug that deserve further research.Keywords
All Related Versions
Funding Information
- Italian Foundation for Cancer Research (IG20736, 2022KME7RY, P20224ZY5P, PNC 0000001 D34Health)
- Italian Ministry of University and Research (IG20736, 2022KME7RY, P20224ZY5P, PNC 0000001 D34Health)
- Next Generation EU (IG20736, 2022KME7RY, P20224ZY5P, PNC 0000001 D34Health)
This publication has 168 references indexed in Scilit:
- Budesonide repairs decreased barrier integrity of eosinophilic nasal polyp epithelial cells caused by PM2.5Clinical and Translational Allergy, 2021
- Epithelial cadherin regulates transition between the naïve and primed pluripotent states in mouse embryonic stem cellsStem Cells, 2020
- An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti‐ and proinflammatory effector genesPharmacology Research & Perspectives, 2016
- Oral budesonide for induction of remission in ulcerative colitisCochrane Database of Systematic Reviews, 2015
- Genetics of ulcerative colitisInflammatory Bowel Diseases, 2011
- Abrogation of E-Cadherin-Mediated Cell–Cell Contact in Mouse Embryonic Stem Cells Results in Reversible LIF-Independent Self-RenewalStem Cells, 2009
- Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumorsInternational Journal of Cancer, 2006
- Preparation of budesonide/γ‐cyclodextrin complexes in supercritical fluids with a novel SEDS methodJournal of Pharmaceutical Sciences, 2006
- Effect of budesonide on the methylation and mRNA expression of the insulin‐like growth factor 2 and c‐myc genes in mouse lung tumorsMolecular Carcinogenesis, 2002
- Relationship between lung tissue and blood plasma concentrations of inhaled budesonideBiopharmaceutics & Drug Disposition, 1993